Morgan Stanley Call 3.5 HUYA 21.0.../ DE000MB7X5Y2 /
03.05.2024 18:59:16 | Diff.- | Geld22:00:32 | Brief22:00:32 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
1,33EUR | - | - Geld Vol: - |
- Brief Vol: - |
HUYA Inc | 3,50 - | 21.06.2024 | Call |
Newsfile Corp
14:11
Funded Capital Launches Revolutionary Financing Program for Ground-Up Constructions, Offering 100% F...
Newsfile Corp
14:08
Abitibi Metals Corp to Participate in THE Mining Investment Event of the North, Canada's Only Tier I...
GlobeNewswire
14:05
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:00
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
14:00
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
14:00
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
14:00
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
14:00
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
14:00
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
14:00
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
14:00
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite